Register Login
Register to leave comments
  • News bot Jan. 8, 2026, 9:19 p.m.

    📋 Verastem, Inc. (VSTM) - Clinical Trial Update

    Filing Date: 2026-01-08

    Accepted: 2026-01-08 16:16:07

    Event Type: Clinical Trial Update

    Event Details:

    Verastem Inc (VSTM) Announces Clinical Trial Update Verastem Inc (VSTM) provided an update on its clinical development programs. Clinical Development Highlights:
    • Clinical Stage: clinical trial, Phase 1
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process
    • Collaboration: LGSOC
      • expected in 2026
      • expected in mid - 2027
      • Targeting RAS 2 nd edition 2025

    🔬 Clinical Development Pipeline (Verastem, Inc.):

    Product Type Development Stage Therapeutic Area Source
    Avutometinib DRUG Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE3 Low Grade Serous Ovarian Cancer ClinicalTrials.gov
    Avutometinib (VS-6766) + Defactinib (VS-6063) DRUG Phase PHASE2 Low Grade Serous Ovarian Cancer ClinicalTrials.gov
    Letrozole DRUG Phase PHASE3 Low Grade Serous Ovarian Cancer ClinicalTrials.gov
    Cetuximab DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    VS-7375 DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Defactinib DRUG Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Anastrozole DRUG Phase PHASE3 Low Grade Serous Ovarian Cancer ClinicalTrials.gov
    Gemcitabine + Nab-paclitaxel DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Stereotactic body radiotherapy RADIATION Phase PHASE2 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Research blood draw PROCEDURE Phase PHASE2 Pancreas Cancer ClinicalTrials.gov
    Tumor biopsy PROCEDURE Phase PHASE2 Pancreas Cancer ClinicalTrials.gov
    Adaptive stereotactic body radiation therapy DEVICE Phase PHASE2 Pancreas Cancer ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    Encorafenib DRUG Phase PHASE1 Cutaneous Melanoma ClinicalTrials.gov
    Pegylated liposomal doxorubicin DRUG Phase PHASE3 Low Grade Serous Ovarian Cancer ClinicalTrials.gov
    Pill Diary OTHER Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    VS-6766/avutometinib DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    Fulvestrant DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Abemaciclib DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    VS-6766 DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Avutometinib (VS-6766) + defactinib DRUG Phase PHASE2 Endometrioid Cancer ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Carboplatin + Pemetrexed + Pembrolizumab DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Verastem Inc
    • CIK: 0001526119
    • Ticker Symbol: VSTM
    • Period End Date: 2026-01-08
    • Document Type: 8-K

Search

News categories